Maithili Life Sciences Private Limited

A pharmaceutical company that produces and trades various products, with a large factory space.

2005 | Hyderabad, Telangana (India) | Active
Last Updated: December 11, 2024

Maithili Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 6.50 Cr
  • Paid Up Capital ₹ 1.95 Cr
  • Company Age 19 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 30.26 Cr
  • Satisfied Charges ₹ 11.13 Cr
  • Revenue Growth 35.93%
  • Profit Growth 54.47%
  • Ebitda 3.73%
  • Net Worth 2.68%
  • Total Assets 46.35%

About Maithili Life Sciences

Maithili Life Sciences Private Limited (MLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 December 2005 and has a history of 19 years and one month. Its registered office is in Hyderabad, Telangana, India.

The Corporate was formerly known as Aditya Sugars Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 1.95 Cr.

The company currently has active open charges totaling ₹30.26 Cr. The company has closed loans amounting to ₹11.13 Cr, as per Ministry of Corporate Affairs (MCA) records.

Tulasi Devasani and Devasani Reddy serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2005PTC048433

  • Company No.

    048433

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Dec 2005

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Maithili Life Sciences Private Limited offer?

Maithili Life Sciences Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Chemical Reagents & Catalysts, Laboratory Reagents, ISO & Quality Management Consultants, Certification Services, Industrial Chemicals & Supplies, Aldehydes.

Who are the key members and board of directors at Maithili Life Sciences?

Board Members (2)

Name Designation Appointment Date Status
Tulasi Devasani Country flag representing In Director 04-Oct-2021 Current
Devasani Reddy Country flag representing In Director 14-Dec-2005 Current

Financial Performance of Maithili Life Sciences.

Maithili Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.93% increase. The company also saw a substantial improvement in profitability, with a 54.47% increase in profit. The company's net worth moved up by a moderate rise of 2.68%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
35.93%
Revenue from Operations
36.00%
Total Assets
46.35%
Profit or Loss
54.47%
Net Worth
2.68%
EBITDA
3.73%

What is the Ownership and Shareholding Structure of Maithili Life Sciences?

In 2022, Maithili Life Sciences had a public holding of 18.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹30.26 Cr

Satisfied Charges

₹11.13 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 21.86 Cr
  • Others : 6.30 Cr
  • Axis Bank Limited : 2.10 Cr

Latest Charge Details

Date Lender Amount Status
01 Oct 2023 Others ₹6.30 Cr Open
23 Nov 2022 Axis Bank Limited ₹2.10 Cr Open
27 Jul 2015 Hdfc Bank Limited ₹21.86 Cr Open
15 May 2014 Andhra Pradeh State Financial Corporation ₹11.13 Cr Satisfied

How Many Employees Work at Maithili Life Sciences?

Maithili Life Sciences has a workforce of 97 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maithili Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maithili Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Maithili Life Sciences

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 6.30 Cr with Charge ID 100811270 was registered on 01 Oct 2023.

    01 Oct 2023

  • Annual General Meeting

    Maithili Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Maithili Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 2.10 Cr with Charge ID 100647126 was registered on 23 Nov 2022.

    23 Nov 2022

  • Charges

    A charge with Hdfc Bank Limited of Rs. 21.86 Cr registered on 27 Jul 2015 with Charge ID 10592000 was modified on 30 Sep 2022.

    30 Sep 2022

  • Director Appointment

    Tulasi Devasani was appointed as a Director was appointed as a Director on 04 Oct 2021 & has been associated with this company since 3 years 4 months .

    04 Oct 2021

Frequently asked questions

  • Maithili Life Sciences Private Limited was incorporated on 14 Dec 2005.

  • The authorized share capital of Maithili Life Sciences Private Limited is ₹ 6.50 Cr and paid-up capital is ₹ 1.95 Cr.

  • Currently 2 directors are associated with Maithili Life Sciences Private Limited.

    • Tulasi Devasani
    • Devasani Gopinath Reddy
  • As per Ministry of Corporate Affairs (Mca), the registered address of Maithili Life Sciences Private Limited is 16-31-Hig/117, Kphb Phase Vi Kukatpalli India, Hyderabad, Telangana, 500072.

  • The corporate identification number (CIN) of Maithili Life Sciences Private Limited is U24232TG2005PTC048433 and the company number is 048433 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Maithili Life Sciences Private Limited is https://www.maithililifesciences.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Maithili Life Sciences Private Limited has risen by 35.93%.

  • As Per 2022 financial reports, 97 employees are currently employed by Maithili Life Sciences Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Maithili Life Sciences Private Limited has experienced an upsurge of 2.68%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Maithili Life Sciences Private Limited amount to ₹ 30.26 Cr.

  • The most recent Balance Sheet for Maithili Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development